CRISPRi screening identifies PIKfyve as a co‐therapeutic target for obinutuzumabYerim Kim, Joo Young Kim, J. Oh et al.|Clinical and Translational Medicine|2025Cited by 1
CD20/TNFR1 dual-targeting antibody enhances lysosome rupture-mediated cell death in B cell lymphomaJeong Ryeol Kim, Joo Young Kim|Research Square|2022Cited by 0